SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

Identifying an acute myocardial infarction on the 12-lead ECG is the most important thing you can learn in ECG interpretation. Time is muscle when treating heart attacks. Missing a ST segment ...

CHICAGO -- A mineralocorticoid receptor antagonist (MRA) was unable to further improve 3-year outcomes of acute myocardial infarction (MI) in the modern era, based on the CLEAR OASIS 9 trial.

In patients with acute myocardial infarction, treatment with the antiinflammatory agent colchicine may improve cardiovascular outcomes; however, results of clinical trials are mixed. New research ...

A total of 7,062 participants were randomized at 104 sites in 14 countries between February 2018 and November 2022. Patients ...

VPDs with very short coupling intervals developing during an acute stage of myocardial infarction would predict the development of early cycled reentry, potentially culminating in VF, and requires ...

Clinicians should be asking patients about cannabis use, particularly if there are cardiovascular concerns, say researchers.

A deescalation strategy involving switching from ticagrelor to clopidogrel in patients with acute myocardial infarction (AMI) ...

A non-transmural myocardial infarction refers to a myocardial infarction that does not involve the full thickness of the myocardium. It was one believed that the development of Q waves indicated ...

US time, the world's first acute myocardial infarction (AMI) antibody drug, SGC001, developed by Sungen Biomedical—an innovative biopharmaceutical company incubated by Beijing Hotgen Biotech Co., Ltd.

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.